Aston Medicals

Companion Diagnostics

Companion Diagnostics

Companion Diagnostics: Cutting Edge Collaboration

Partner with the Leica Biosystems Companion Diagnostics (CDx) team for your next diagnostic development project. Our CDx team collaborates with leading biotechnology and pharmaceutical companies. Together, we develop and ultimately commercialize cutting-edge diagnostic test solutions that help identify patients who are likely to benefit from our partners’ emerging therapies, a critical element of personalized medicine.

We are uniquely positioned to drive personalized healthcare by ensuring patients receive a timely and accurate diagnosis, a critical part of VISION24, our vision statement.

  • Our in vitro diagnostic (IVD)CDx products are developed by a CDx team with extensive diagnostics and pharmaceutical industry experience.
  • Likewise, assay development is carried out under Design Control standards. A standardized process also allows for consistent output and robust diagnostic products.
  • Each CDx project is assigned to a cross-functional team that works closely with our Pharma Partners throughout the IVD development process.

Featured Products

Leica HER2 FISH System for BOND Fully Automated HER2 FISH Solution

Download Brouchure

The Leica HER2 FISH System for BOND combines PathVysion®* LSI® HER2/CEP17® FISH probes (supplied by Abbott Molecular Inc.) and advanced BOND automation.

Now laboratories, pathologists, and ultimately patients can benefit from easy and accurate FISH assessment of HER2 gene status in breast cancer tissue.

  • Easy – eliminate manual complexity and increase standardization through automation
  • Efficient – create a Lean workflow with single or batched cases
  • Accurate – deliver accurate results for high diagnostic confidence

Name Info Cat No Principal
Name Info Cat No Principal

Bond Oracle HER2 IHC System

Download Brouchure

The Bond Oracle HER2 IHC System is a fully-automated assay to accurately determine HER2 oncoprotein status in breast cancer tissue as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered.

  • Accurate – optimized to precisely separate 1+ and 2+ cases gives you excellent FISH concordance, reducing avoidable FISH requests.
  • Drive Consistency – standardized protocols for uniform staining, decreased process variation, and consistent results.
  • Maximize Efficiency – full automation frees up your skilled staff for other high-value tasks.
  • A Complete Solution – integrated ready-to-use reagents, control slides, and advanced automation ensure quality and consistency.

Name Info Cat No Principal
Name Info Cat No Principal